Skip to main content
Earnings Labs
Precigen, Inc. logo

Precigen, Inc. (PGEN)

NASDAQ·Healthcare·Biotechnology

$4.88

+2.63%

Mkt Cap $1.34B

Analyst Ratings

Buy

3

Hold

0

Sell

0

Price Target (1 analysts)

$6.00

Range $6.00$6.00

Implied Upside

+23.1%

Consensus $6.00 vs current $4.88